We have located links that may give you full text access.
A nanosystem composed of upconversion nanoparticles and N, N-diethyl-p-phenylenediamine for fluorimetric determination of ferric ion.
Mikrochimica Acta 2018 July 18
A system composed of upconversion nanoparticles (UCNPs) and N,N-diethyl-p-phenylenediamine (EPA) is shown to be a useful probe for highly sensitive and selective fluorometric determination of ferric ion. The fluorescence of the UCNPs (under the 980 nm excitation) has peaks at 546, 657, 758 and 812 nm. EPA is readily oxidized by Fe(III) to generate a dye with a peak at 552 nm. This causes an inner filter effect on the fluorescence peaks at 546 nm, whereas the emissions at 657, 758 and 812 nm remained unchanged. Therefore, the iron concentration can be quantified by measurement of the ratio of fluorescence at 546 and 758. Under optimal condition, the ratio drops linearly in the 0.25 to 50 μM. Fe(III) concentration ranges, with a detection limit of 0.25 μM. The method is highly selective and was applied to the analysis of spiked samples (wastewater) where it gave recoveries of between 100.9 and 107.3%; and RSD values between 0.8 and 1.4%. Results are approximately the same as those obtained by AAS. Graphical abstract A method is presented for fluorimetric determination of Fe(III). Fe(III) reacts with N,N-diethyl-p-phenylenediamine (EPA) to generate EPA oxide. The fluorescence peaking at 546 nm is reduced in presence of oxidized EPA via an inner filter.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app